Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongchun Yu

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 23, 2013
Chd4 and associated proteins function as corepressors of Sox9 expression during BMP-2-induced chondrogenesisFenyong Sun, Qingyuan Yang, Wenhao Weng, et al.
Journal of Cellular Physiology|May 29, 2008
Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoterQiuhui Pan, Yongchun Yu, Qiongyu Chen, et al.
Cell Death & Disease|September 30, 2021
Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation in liver cancer cellsCongcong Zhang, Yongjie Niu, Zhixian Wang, et al.
Cancer Chemotherapy and Pharmacology|November 23, 2015
A novelly synthesized phenanthroline derivative is a promising DNA-damaging anticancer agent inhibiting G1/S checkpoint transition and inducing cell apoptosis in cancer cellsNi Zhen, Qingyuan Yang, Qiong Wu, et al.
Oncology Reports|February 1, 2014
YY1-C/EBPα-miR34a regulatory circuitry is involved in renal cell carcinoma progressionWenhao Weng, Minli Wang, Suhong Xie, et al.
Oncology Reports|June 4, 2014
CD166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through AKTWenjun Yu, Jiayi Wang, Lifang Ma, et al.
Molecular Carcinogenesis|December 31, 2022
RBM4 inhibits the growth of clear cell renal cell carcinoma by enhancing the stability of p53 mRNAWengang Jian, Wei Xue, Tengda Wang, et al.
Biochemical and Biophysical Research Communications|January 12, 2011
c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinomaWenhao Weng, Qinyuan Yang, Miaolong Huang, et al.
Oncotarget|September 9, 2017
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinomaHongyuan Jiang, Xiao Zhang, Yuquan Tao, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 14, 2021
Yu-Ping-Feng Formula Exerts Antilung Cancer Effects by Remodeling the Tumor Microenvironment through Regulating Myeloid-Derived Suppressor CellsYuli Wang, Ningyang Sun, Yingbin Luo, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 23, 2013
Chd4 and associated proteins function as corepressors of Sox9 expression during BMP-2-induced chondrogenesisFenyong Sun, Qingyuan Yang, Wenhao Weng, et al.
Journal of Cellular Physiology|May 29, 2008
Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoterQiuhui Pan, Yongchun Yu, Qiongyu Chen, et al.
Cell Death & Disease|September 30, 2021
Corosolic acid inhibits cancer progression by decreasing the level of CDK19-mediated O-GlcNAcylation in liver cancer cellsCongcong Zhang, Yongjie Niu, Zhixian Wang, et al.
Cancer Chemotherapy and Pharmacology|November 23, 2015
A novelly synthesized phenanthroline derivative is a promising DNA-damaging anticancer agent inhibiting G1/S checkpoint transition and inducing cell apoptosis in cancer cellsNi Zhen, Qingyuan Yang, Qiong Wu, et al.
Oncology Reports|February 1, 2014
YY1-C/EBPα-miR34a regulatory circuitry is involved in renal cell carcinoma progressionWenhao Weng, Minli Wang, Suhong Xie, et al.
Oncology Reports|June 4, 2014
CD166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through AKTWenjun Yu, Jiayi Wang, Lifang Ma, et al.
Molecular Carcinogenesis|December 31, 2022
RBM4 inhibits the growth of clear cell renal cell carcinoma by enhancing the stability of p53 mRNAWengang Jian, Wei Xue, Tengda Wang, et al.
Biochemical and Biophysical Research Communications|January 12, 2011
c-Myc inhibits TP53INP1 expression via promoter methylation in esophageal carcinomaWenhao Weng, Qinyuan Yang, Miaolong Huang, et al.
Oncotarget|September 9, 2017
Prognostic and clinicopathologic significance of SIRT1 expression in hepatocellular carcinomaHongyuan Jiang, Xiao Zhang, Yuquan Tao, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 14, 2021
Yu-Ping-Feng Formula Exerts Antilung Cancer Effects by Remodeling the Tumor Microenvironment through Regulating Myeloid-Derived Suppressor CellsYuli Wang, Ningyang Sun, Yingbin Luo, et al.
Pageof 11